# Probiotics Women's Health Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/probiotics-women-s-health-randomized-trial-evidence-review
Category: evidence-review
Summary: Probiotics Women's Health Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass 
Last reviewed: 2026-07-31
Reviewed by: Migaku Evidence Review
# Probiotics Women's Health Randomized Trial: What the Evidence Says

## Quick Answer

Probiotics Women's Health Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 randomized trial.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Probiotic supplementation during pregnancy for vaginal microbiota improvement and pathogen clearance: A systematic review and meta‐analysis | systematic review | 1 | 2026-04-28 | 10.1111/aogs.70234 |
| Effect of Probiotic Supplementation on Reproductive Outcomes of Women With Polycystic Ovary Syndrome Who Are Candidates for Intrauterine Insemination: A Randomized, Double‐Blind, Placebo‐Controlled Trial | randomized trial | 2 | 2026-03-03 | 10.1002/edm2.70185 |

## What The Sources Report

- Rising estrogen and progesterone levels promote glycogen accumulation in the vaginal epithelium, fostering robust lactobacilli proliferation.Yet this glycogen-rich milieu also supports adherence and overgrowth of opportunistic pathogens includingspeciesand Group B Streptococcus (GBS),placing pregnant women at heightened risk of vulvovaginal candidiasis (VVC) and GBS colonization. [Liu Zimo (2026); evidence level 1]
- Hormonal and metabolic disturbances in women with PCOS put them at increased risk of multiple reproductive, oncological, cardiometabolic, and psychological complications. [Behroozilak Tahereh (2026); evidence level 2]
- However, some evidence cannot support the beneficial effect of adding IUI ovulation induction protocols on fertility outcomes among women with PCOS. [Behroozilak Tahereh (2026); evidence level 2]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. There is trial evidence in the current set, but population and intervention details still matter. For probiotics women's health randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Liu Zimo (2026). Probiotic supplementation during pregnancy for vaginal microbiota improvement and pathogen clearance: A systematic review and meta‐analysis. DOI: 10.1111/aogs.70234. PMCID: PMC13191816. PMID: 42047468. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13191816/
- Behroozilak Tahereh (2026). Effect of Probiotic Supplementation on Reproductive Outcomes of Women With Polycystic Ovary Syndrome Who Are Candidates for Intrauterine Insemination: A Randomized, Double‐Blind, Placebo‐Controlled Trial. DOI: 10.1002/edm2.70185. PMCID: PMC12956837. PMID: 41776814. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12956837/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.